129 related articles for article (PubMed ID: 26899479)
1. Denosumab: An Alternative Therapy for the Management of Giant Cell Lesions.
O'Connell JE; Kearns GJ
J Oral Maxillofac Surg; 2016 May; 74(5):873. PubMed ID: 26899479
[No Abstract] [Full Text] [Related]
2. Denosumab treatment of giant cell tumour of bone.
Balke M
Lancet Oncol; 2013 Aug; 14(9):801-2. PubMed ID: 23867210
[No Abstract] [Full Text] [Related]
3. Denosumab: Excellent response of metastatic giant cell tumor of the bone.
Ulas A; Bulent Akinci M; Silay K; Sendur MA; Sener Dede D; Yalcin B
J BUON; 2015; 20(2):666-7. PubMed ID: 26011370
[No Abstract] [Full Text] [Related]
4. Denosumab: Current Use in the Treatment of Primary Bone Tumors.
Savvidou OD; Bolia IK; Chloros GD; Papanastasiou J; Koutsouradis P; Papagelopoulos PJ
Orthopedics; 2017 Jul; 40(4):204-210. PubMed ID: 28732103
[TBL] [Abstract][Full Text] [Related]
5. Denosumab: a new treatment option for giant cell tumor of bone.
Lewin J; Thomas D
Drugs Today (Barc); 2013 Nov; 49(11):693-700. PubMed ID: 24308016
[TBL] [Abstract][Full Text] [Related]
6. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone.
Branstetter DG; Nelson SD; Manivel JC; Blay JY; Chawla S; Thomas DM; Jun S; Jacobs I
Clin Cancer Res; 2012 Aug; 18(16):4415-24. PubMed ID: 22711702
[TBL] [Abstract][Full Text] [Related]
7. Early evaluation of the therapeutic effect of denosumab on tartrate-resistant acid phosphatase 5b expression in a giant cell tumor of bone: a case report.
Watanabe N; Matsumoto S; Shimoji T; Ae K; Tanizawa T; Gokita T; Motoi N; Ueno T; Koizumi M
BMC Res Notes; 2014 Sep; 7():608. PubMed ID: 25193435
[TBL] [Abstract][Full Text] [Related]
8. Golden bullet-denosumab: early rapid response of metastatic giant cell tumor of the bone.
Demirsoy U; Karadogan M; Selek Ö; Anik Y; Aksu G; Müezzinoglu B; Corapcioglu F
J Pediatr Hematol Oncol; 2014 Mar; 36(2):156-8. PubMed ID: 24072245
[TBL] [Abstract][Full Text] [Related]
9. Critical hypercalcemia following discontinuation of denosumab therapy for metastatic giant cell tumor of bone.
Gossai N; Hilgers MV; Polgreen LE; Greengard EG
Pediatr Blood Cancer; 2015 Jun; 62(6):1078-80. PubMed ID: 25556556
[TBL] [Abstract][Full Text] [Related]
10. Denosumab: a breakthrough in treatment of giant-cell tumour of bone?
Balke M; Hardes J
Lancet Oncol; 2010 Mar; 11(3):218-9. PubMed ID: 20149737
[No Abstract] [Full Text] [Related]
11. RANKL, denosumab, and giant cell tumor of bone.
Thomas DM
Curr Opin Oncol; 2012 Jul; 24(4):397-403. PubMed ID: 22581354
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of denosumab in giant-cell tumour of bone.
Kyrgidis A; Toulis K
Lancet Oncol; 2010 Jun; 11(6):513-4. PubMed ID: 20522379
[No Abstract] [Full Text] [Related]
13. Safety of denosumab in giant-cell tumour of bone.
Thomas D; Carriere P; Jacobs I
Lancet Oncol; 2010 Sep; 11(9):815. PubMed ID: 20816372
[No Abstract] [Full Text] [Related]
14. Denosumab for the treatment of giant cell tumor of the bone.
Brodowicz T; Hemetsberger M; Windhager R
Future Oncol; 2015; 11(13):1881-94. PubMed ID: 26161925
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study.
Chawla S; Henshaw R; Seeger L; Choy E; Blay JY; Ferrari S; Kroep J; Grimer R; Reichardt P; Rutkowski P; Schuetze S; Skubitz K; Staddon A; Thomas D; Qian Y; Jacobs I
Lancet Oncol; 2013 Aug; 14(9):901-8. PubMed ID: 23867211
[TBL] [Abstract][Full Text] [Related]
16. Denosumab, a Potential Alternative to the Surgical Treatment of Distal Radius Giant Cell Tumor of Bone: Case Report.
Park MJ; Ganjoo KN; Ladd AL
J Hand Surg Am; 2015 Aug; 40(8):1620-4. PubMed ID: 25935517
[TBL] [Abstract][Full Text] [Related]
17. Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab.
Hakozaki M; Tajino T; Yamada H; Hasegawa O; Tasaki K; Watanabe K; Konno S
Diagn Pathol; 2014 Jun; 9():111. PubMed ID: 24906559
[TBL] [Abstract][Full Text] [Related]
18. Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls.
Roitman PD; Jauk F; Farfalli GL; Albergo JI; Aponte-Tinao LA
Hum Pathol; 2017 May; 63():89-97. PubMed ID: 28235628
[TBL] [Abstract][Full Text] [Related]
19. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
[TBL] [Abstract][Full Text] [Related]
20. [Denosumab may be a supplement to the surgical treatment of giant cell tumours of bone].
Sørensen AL; Hansen RL; Jørgensen PH
Ugeskr Laeger; 2016 Sep; 178(36):. PubMed ID: 27593237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
